Do analysts prefer CRVL or TEM?

Tempus AI has a consensus target price of $79.37, indicating a potential upside of 10.85%. Given Tempus AI's stronger consensus rating and higher possible upside, analysts clearly believe Tempus AI is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tempus AI 1 Sell rating(s) 10 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.45

Which has better valuation & earnings, CRVL or TEM?

CorVel has higher earnings, but lower revenue than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 4.50 $110.34M $2.38 36.00 Tempus AI $1.27B 10.27 -$245.03M -$1.06 N/A

Is CRVL or TEM more profitable?

CorVel has a net margin of 12.02% compared to Tempus AI's net margin of -12.54%. CorVel's return on equity of 30.20% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 12.02% 30.20% 18.06% Tempus AI -12.54% -47.00% -9.44%

Does the media prefer CRVL or TEM?

In the previous week, Tempus AI had 12 more articles in the media than CorVel. MarketBeat recorded 17 mentions for Tempus AI and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat Tempus AI's score of 0.68 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 6 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor BTSG or CRVL?

In the previous week, BrightSpring Health Services had 3 more articles in the media than CorVel. MarketBeat recorded 8 mentions for BrightSpring Health Services and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat BrightSpring Health Services' score of 1.03 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CRVL or FMS?

Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.43, suggesting a potential upside of 6.16%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Fresenius Medical Care AG & Co. KGaA 5 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.58

Does the media prefer CRVL or FMS?

In the previous week, Fresenius Medical Care AG & Co. KGaA had 3 more articles in the media than CorVel. MarketBeat recorded 8 mentions for Fresenius Medical Care AG & Co. KGaA and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat Fresenius Medical Care AG & Co. KGaA's score of 0.92 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend DVA or CRVL?

DaVita currently has a consensus price target of $235.86, suggesting a potential upside of 34.92%. Given DaVita's stronger consensus rating and higher probable upside, research analysts plainly believe DaVita is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DaVita 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger earnings & valuation, DVA or CRVL?

DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DaVita $13.64B 0.81 $746.80M $13.58 12.87 CorVel $958.53M 4.50 $110.34M $2.38 36.00

Is DVA or CRVL more profitable?

CorVel has a net margin of 12.02% compared to DaVita's net margin of 6.49%. CorVel's return on equity of 30.20% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets DaVita 6.49% -225.93% 5.42% CorVel 12.02% 30.20% 18.06%

Does the media refer more to DVA or CRVL?

In the previous week, DaVita had 12 more articles in the media than CorVel. MarketBeat recorded 17 mentions for DaVita and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat DaVita's score of 0.62 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 7 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend HNGE or CRVL?

Hinge Health presently has a consensus target price of $118.93, suggesting a potential upside of 3.23%. Given Hinge Health's stronger consensus rating and higher probable upside, research analysts clearly believe Hinge Health is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hinge Health 0 Sell rating(s) 2 Hold rating(s) 15 Buy rating(s) 2 Strong Buy rating(s) 3.00 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation & earnings, HNGE or CRVL?

CorVel has higher revenue and earnings than Hinge Health. CorVel is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hinge Health $587.86M 15.81 -$528.26M $1.96 58.78 CorVel $958.53M 4.50 $110.34M $2.38 36.00

Is HNGE or CRVL more profitable?

Hinge Health has a net margin of 21.02% compared to CorVel's net margin of 12.02%. Hinge Health's return on equity of 66.96% beat CorVel's return on equity. Company Net Margins Return on Equity Return on Assets Hinge Health 21.02% 66.96% 19.70% CorVel 12.02% 30.20% 18.06%

Does the media refer more to HNGE or CRVL?

In the previous week, Hinge Health had 10 more articles in the media than CorVel. MarketBeat recorded 15 mentions for Hinge Health and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat Hinge Health's score of 0.66 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 7 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

CorVel (CRVL) Competitors

$85.69 -0.81 (-0.94%)

Closing price 11/13/2026 04:00 PM Eastern

Extended Trading

$85.76 +0.08 (+0.09%)

As of 11/13/2026 07:30 PM Eastern

Compare

CRVL vs. TEM, BTSG, FMS, DVA, and HNGE

Should you buy CorVel stock or one of its competitors? CorVel's main competitors and comparable companies include Tempus AI (TEM), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), and Hinge Health (HNGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does CorVel compare to Tempus AI?

CorVel (NASDAQ:CRVL) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Tempus AI has a consensus target price of $79.37, indicating a potential upside of 10.85%. Given Tempus AI's stronger consensus rating and higher possible upside, analysts clearly believe Tempus AI is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tempus AI	1 Sell rating(s)	10 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.45

CorVel has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.61, suggesting that its stock price is 261% more volatile than the broader market.

CorVel has a net margin of 12.02% compared to Tempus AI's net margin of -12.54%. CorVel's return on equity of 30.20% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	12.02%	30.20%	18.06%
Tempus AI	-12.54%	-47.00%	-9.44%

CorVel has higher earnings, but lower revenue than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	4.50	$110.34M	$2.38	36.00
Tempus AI	$1.27B	10.27	-$245.03M	-$1.06	N/A

51.4% of CorVel shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 39.7% of CorVel shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Tempus AI had 12 more articles in the media than CorVel. MarketBeat recorded 17 mentions for Tempus AI and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat Tempus AI's score of 0.68 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	6 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

CorVel beats Tempus AI on 9 of the 16 factors compared between the two stocks.

How does CorVel compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

CorVel has a net margin of 12.02% compared to BrightSpring Health Services' net margin of 2.69%. CorVel's return on equity of 30.20% beat BrightSpring Health Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.69%	18.56%	6.03%
CorVel	12.02%	30.20%	18.06%

BrightSpring Health Services presently has a consensus price target of $77.81, indicating a potential upside of 9.27%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities analysts plainly believe BrightSpring Health Services is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	3.11
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

BrightSpring Health Services has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, CorVel has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than CorVel. CorVel is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	1.10	$190.67M	$1.85	38.49
CorVel	$958.53M	4.50	$110.34M	$2.38	36.00

In the previous week, BrightSpring Health Services had 3 more articles in the media than CorVel. MarketBeat recorded 8 mentions for BrightSpring Health Services and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat BrightSpring Health Services' score of 1.03 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

51.4% of CorVel shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 39.7% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

BrightSpring Health Services beats CorVel on 9 of the 17 factors compared between the two stocks.

How does CorVel compare to Fresenius Medical Care AG & Co. KGaA?

CorVel (NASDAQ:CRVL) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than CorVel. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	4.50	$110.34M	$2.38	36.00
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.53	$1.11B	$1.73	12.75

In the previous week, Fresenius Medical Care AG & Co. KGaA had 3 more articles in the media than CorVel. MarketBeat recorded 8 mentions for Fresenius Medical Care AG & Co. KGaA and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat Fresenius Medical Care AG & Co. KGaA's score of 0.92 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

51.4% of CorVel shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 39.7% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.43, suggesting a potential upside of 6.16%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58

CorVel has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

CorVel has a net margin of 12.02% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.23%. CorVel's return on equity of 30.20% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	12.02%	30.20%	18.06%
Fresenius Medical Care AG & Co. KGaA	4.23%	9.08%	4.04%

Summary

CorVel beats Fresenius Medical Care AG & Co. KGaA on 11 of the 15 factors compared between the two stocks.

How does CorVel compare to DaVita?

DaVita (NYSE:DVA) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	0.81	$746.80M	$13.58	12.87
CorVel	$958.53M	4.50	$110.34M	$2.38	36.00

CorVel has a net margin of 12.02% compared to DaVita's net margin of 6.49%. CorVel's return on equity of 30.20% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.49%	-225.93%	5.42%
CorVel	12.02%	30.20%	18.06%

DaVita currently has a consensus price target of $235.86, suggesting a potential upside of 34.92%. Given DaVita's stronger consensus rating and higher probable upside, research analysts plainly believe DaVita is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

90.1% of DaVita shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 1.9% of DaVita shares are held by company insiders. Comparatively, 39.7% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

DaVita has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, CorVel has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market.

In the previous week, DaVita had 12 more articles in the media than CorVel. MarketBeat recorded 17 mentions for DaVita and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat DaVita's score of 0.62 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	7 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita and CorVel tied by winning 8 of the 16 factors compared between the two stocks.

How does CorVel compare to Hinge Health?

Hinge Health (NYSE:HNGE) and CorVel (NASDAQ:CRVL) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

Hinge Health has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, CorVel has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market.

In the previous week, Hinge Health had 10 more articles in the media than CorVel. MarketBeat recorded 15 mentions for Hinge Health and 5 mentions for CorVel. CorVel's average media sentiment score of 1.12 beat Hinge Health's score of 0.66 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	7 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health presently has a consensus target price of $118.93, suggesting a potential upside of 3.23%. Given Hinge Health's stronger consensus rating and higher probable upside, research analysts clearly believe Hinge Health is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	0 Sell rating(s)	2 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.00
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Hinge Health has a net margin of 21.02% compared to CorVel's net margin of 12.02%. Hinge Health's return on equity of 66.96% beat CorVel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	21.02%	66.96%	19.70%
CorVel	12.02%	30.20%	18.06%

51.4% of CorVel shares are held by institutional investors. 18.9% of Hinge Health shares are held by insiders. Comparatively, 39.7% of CorVel shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

CorVel has higher revenue and earnings than Hinge Health. CorVel is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	15.81	-$528.26M	$1.96	58.78
CorVel	$958.53M	4.50	$110.34M	$2.38	36.00

Summary

Hinge Health beats CorVel on 11 of the 17 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRVL vs. The Competition

Export

Metric	CorVel	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.35B	$10.82B	$7.84B	$12.19B
Dividend Yield	N/A	2.54%	2.46%	4.53%
P/E Ratio	36.00	36.37	34.71	28.44
Price / Sales	4.50	2.15	8.66	5.84
Price / Cash	31.14	23.34	21.93	22.49
Price / Book	10.02	3.71	4.35	3.76
Net Income	$110.34M	$335.01M	$3.51B	$390.55M
7 Day Performance	3.04%	-1.06%	-1.49%	-0.33%
1 Month Performance	6.58%	-0.57%	-2.55%	-4.82%
1 Year Performance	15.53%	21.17%	0.92%	-5.83%

CorVel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRVL CorVel	1.057 of 5 stars	$85.69 -0.9%	N/A	+16.6%	$4.35B	$958.53M	36.00	5,239	News Coverage Analyst Upgrade Insider Trade
TEM Tempus AI	2.5029 of 5 stars	$79.38 +1.1%	$79.37 0.0%	+5.4%	$14.37B	$1.43B	N/A	3,800
BTSG BrightSpring Health Services	3.6556 of 5 stars	$68.85 +3.9%	$77.81 +13.0%	+124.3%	$13.63B	$15.25B	37.24	23,500	Positive News
FMS Fresenius Medical Care AG & Co. KGaA	3.5734 of 5 stars	$21.80 -3.6%	$23.43 +7.4%	-6.9%	$11.72B	$22.20B	11.31	1,488	Gap Up
DVA DaVita	4.4188 of 5 stars	$181.65 -2.2%	$235.86 +29.8%	+42.1%	$11.60B	$14.17B	13.39	78,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRVL) was last updated on 11/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CorVel (CRVL) Competitors